| Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ... The Lancet 391 (10127), 1263-1273, 2018 | 984 | 2018 |
| Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind … JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... The Lancet Neurology 16 (12), 976-986, 2017 | 601 | 2017 |
| Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial JF Howard, V Bril, T Vu, C Karam, S Peric, T Margania, H Murai, ... The Lancet Neurology 20 (7), 526-536, 2021 | 305 | 2021 |
| Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis S Muppidi, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... Muscle & nerve 60 (1), 14-24, 2019 | 193 | 2019 |
| SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia T Schmitz-Hubsch, P Giunti, DA Stephenson, C Globas, L Baliko, F Saccà, ... Neurology 71 (7), 486-492, 2008 | 160 | 2008 |
| Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression M Moccia, R Lanzillo, R Palladino, KCM Chang, T Costabile, C Russo, ... Multiple Sclerosis Journal 22 (5), 659-667, 2016 | 159 | 2016 |
| A genome-wide association meta-analysis identifies a novel locus at 17q11. 2 associated with sporadic amyotrophic lateral sclerosis I Fogh, A Ratti, C Gellera, K Lin, C Tiloca, V Moskvina, L Corrado, ... Human molecular genetics 23 (8), 2220-2231, 2014 | 140 | 2014 |
| Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study C Criscuolo, L Chessa, S Di Giandomenico, P Mancini, F Saccà, ... Neurology 66 (8), 1207-1210, 2006 | 134 | 2006 |
| Dimethyl fumarate mediates Nrf2-dependent mitochondrial biogenesis in mice and humans G Hayashi, M Jasoliya, S Sahdeo, F Saccà, C Pane, A Filla, A Marsili, ... Human molecular genetics 26 (15), 2864-2873, 2017 | 109 | 2017 |
| Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis P Iaffaldano, G Lucisano, C Pozzilli, V Brescia Morra, A Ghezzi, ... Brain 138 (11), 3275-3286, 2015 | 85 | 2015 |
| A combined nucleic acid and protein analysis in Friedreich ataxia: implications for diagnosis, pathogenesis and clinical trial design F Sacca, G Puorro, A Antenora, A Marsili, A Denaro, R Piro, P Sorrentino, ... PLoS One 6 (3), e17627, 2011 | 79 | 2011 |
| Long‐term safety and efficacy of Eculizumab in Aquaporin‐4 IgG‐positive NMOSD DM Wingerchuk, K Fujihara, J Palace, A Berthele, M Levy, HJ Kim, ... Annals of neurology 89 (6), 1088-1098, 2021 | 76 | 2021 |
| Vascular smooth muscle cell dysfunction in patients with migraine R Napoli, V Guardasole, E Zarra, M Matarazzo, C D'Anna, F Saccà, ... Neurology 72 (24), 2111-2114, 2009 | 76 | 2009 |
| Recombinant human erythropoietin increases frataxin protein expression without increasing mRNA expression F Acquaviva, I Castaldo, A Filla, M Giacchetti, D Marmolino, A Monticelli, ... The Cerebellum 7, 360-365, 2008 | 71 | 2008 |
| Assessing association of comorbidities with treatment choice and persistence in MS: a real-life multicenter study A Laroni, A Signori, GT Maniscalco, R Lanzillo, CV Russo, E Binello, ... Neurology 89 (22), 2222-2229, 2017 | 68 | 2017 |
| The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests F Saccà, T Costabile, A Carotenuto, R Lanzillo, M Moccia, C Pane, ... Multiple Sclerosis Journal 23 (9), 1289-1296, 2017 | 68 | 2017 |
| Multiple hormone deficiencies in chronic heart failure M Arcopinto, A Salzano, E Bossone, F Ferrara, E Bobbio, D Sirico, O Vriz, ... International Journal of Cardiology 184, 421-423, 2015 | 65 | 2015 |
| A gene expression phenotype in lymphocytes from Friedreich ataxia patients G Coppola, R Burnett, S Perlman, R Versano, F Gao, H Plasterer, M Rai, ... Annals of neurology 70 (5), 790-804, 2011 | 63 | 2011 |
| Novel mutation of SACS gene in a Spanish family with autosomal recessive spastic ataxia C Criscuolo, F Saccà, G De Michele, P Mancini, O Combarros, J Infante, ... Movement Disorders: Official Journal of the Movement Disorder Society 20 (10 …, 2005 | 63 | 2005 |
| Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis M Filippi, R Danesi, T Derfuss, M Duddy, P Gallo, R Gold, EK Havrdová, ... Journal of neurology, 1-8, 2022 | 62 | 2022 |
alessandro fillaUniversity Federico II Naples在 unina.it 的电子邮件经过验证
